Study of Two Pulse Width Settings in TENS Therapy for Children Aged 5 to 17 with Bedwetting

What this Trial Is About

This research investigates the use of Transcutaneous Electrical Nerve Stimulation TENS therapy to treat primary nocturnal enuresis bedwetting in children aged 5 to 17 years. Children referred to a pediatric urology clinic who have not improved after behavioral modifications will be offered either a bedwetting alarm or TENS therapy. The study aims to compare two different pulse widths of TENS to understand their effects on nighttime wetting episodes and bladder symptoms. Participants will be randomly assigned to one of two groups one receiving TENS with a high pulse width of 260 microseconds and the other with a low pulse width of 50 microseconds. Each child will use the TENS unit with electrodes placed on the medial ankle along the posterior tibial nerve for 30 minutes at bedtime every night for 30 days. Intensity will be set based on the childs sensitivity, and families will be instructed on device use. There is no placebo group all participants receive active treatment. During the study, parents and children will keep nightly diaries tracking the frequency and severity of bedwetting using a wet sheet scale. Before and after treatment, they will complete the Bowel & Bladder Questionnaire to assess bladder symptoms. Follow-up visits will occur after one month to evaluate progress and any side effects. The main outcome measured is the percentage of wet nights over 30 days, alongside severity and symptom questionnaire results. Participation includes daily monitoring and a month of treatment.

Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children